Laura Fabbri, MD, discusses bridging idiopathic pulmonary fibrosis (IPF) and oncology research and putting patients at the center of trial design.
Laura Fabbri, MD
Advertisement
Fabbri, MD, from Imperial College London.
Articles by Laura Fabbri, MD
Laura Fabbri, MD, says patient wishes should guide care decisions in IPF and lung cancer overlap.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Extension Studies in TPIP Show Promise in PAH, PH-ILD
2
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
3
Inhaled Amikacin Raises Culture Conversion in New MAC Lung Disease
4
Bronchiectasis GWAS Highlights Candidate Targets Shared With COPD
5